OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2024
(4)
2023
(2)
2021
(2)
2017
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma.
Not available
S-EPMC5746164
|
biostudies-literature
Cite
Rare EIF4A2 variants are associated with a neurodevelopmental disorder characterized by intellectual disability, hypotonia, and epilepsy.
Not available
S-EPMC9892767
|
biostudies-literature
Cite
A MT-TL1 variant identified by whole exome sequencing in an individual with intellectual disability, epilepsy, and spastic tetraparesis.
Not available
S-EPMC8440635
|
biostudies-literature
Cite
Incidence, management and outcomes in hepatic artery complications after paediatric liver transplantation: protocol of the retrospective, international, multicentre HEPATIC Registry.
Not available
S-EPMC11177692
|
biostudies-literature
Cite
Solving unsolved rare neurological diseases-a Solve-RD viewpoint.
Not available
S-EPMC8440537
|
biostudies-literature
Cite
Comprehensive reanalysis for CNVs in ES data from unsolved rare disease cases results in new diagnoses.
Not available
S-EPMC11513043
|
biostudies-literature
Cite
Clinical, genetic, epidemiologic, evolutionary, and functional delineation of
TSPEAR
-related autosomal recessive ectodermal dysplasia 14.
Not available
S-EPMC10064225
|
biostudies-literature
Cite
An interconnected data infrastructure to support large-scale rare disease research.
Not available
S-EPMC11413801
|
biostudies-literature
Cite
Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries.
Not available
S-EPMC10771125
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets